Literature DB >> 19682018

What is the nature of the emergence phenomenon when using intravenous or intramuscular ketamine for paediatric procedural sedation?

Greg Treston1, Anthony Bell, Rob Cardwell, Gavin Fincher, Dip Chand, Geoff Cashion.   

Abstract

OBJECTIVE: Ketamine has become the drug most favoured by emergency physicians for sedation of children in the ED. Some emergency physicians do not use ketamine for paediatric procedural sedation (PPS) because of concern about emergence delirium on recovery. The present study set out to determine the true incidence and nature of this phenomenon.
METHODS: Prospective data relating to any emergence agitation, crying, hallucinations, dreams, altered perceptions, delirium and necessary interventions were recorded in consecutive cases of ketamine PPS from March 2002 to June 2007, and analysed. Standard inclusion and exclusion criteria for the use of ketamine were followed.
RESULTS: A total of 745 prospective data collection records were available for analysis over the 5 year period. Of all, 93 (12.5%) children cried on awakening when recovering from PPS, 291 (39%) experienced pleasant altered perceptions and 16 (2.1%) experienced what was called 'emergence delirium'. None required any active treatment and all except one settled within 20 min. There was no evidence of an increased rate of nightmares on telephone follow up in the weeks post procedure.
CONCLUSION: The belief that ketamine, in the doses used for ED PPS, causes frequent emergence delirium is flawed. A pleasant emergence phenomenon is common, but is not distressing for the child, and has no long-term (up to 30 days) negative sequelae. Rarely, there is anxiety or distress on awakening from ketamine sedation, which settles spontaneously. This should not deter emergency physicians from using ketamine for PPS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682018     DOI: 10.1111/j.1742-6723.2009.01203.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  7 in total

1.  Ketamine-Based Anesthetic Protocols and Evoked Potential Monitoring: A Risk/Benefit Overview.

Authors:  Nicoleta Stoicea; Gregory Versteeg; Diana Florescu; Nicholas Joseph; Juan Fiorda-Diaz; Víctor Navarrete; Sergio D Bergese
Journal:  Front Neurosci       Date:  2016-02-16       Impact factor: 4.677

2.  Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial.

Authors:  Mehran Sotoodehnia; Mozhgan Farmahini-Farahani; Arash Safaie; Fatemeh Rasooli; Alireza Baratloo
Journal:  Korean J Pain       Date:  2019-04-01

3.  Low-Dose Fentanyl, Propofol, Midazolam, Ketamine and Lidocaine Combination vs. Regular Dose Propofol and Fentanyl Combination for Deep Sedation Induction; a Randomized Clinical Trial.

Authors:  Afshin Amini; Ali Arhami Dolatabadi; Hamid Kariman; Hamidreza Hatamabadi; Elham Memary; Sohrab Salimi; Shahram Shokrzadeh
Journal:  Emerg (Tehran)       Date:  2018-10-02

Review 4.  The multiple faces of ketamine in anaesthesia and analgesia.

Authors:  Silvia Natoli
Journal:  Drugs Context       Date:  2021-04-23

Review 5.  Clinical Uses of Ketamine in Children: A Narrative Review.

Authors:  Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez; Rajeswar Kumar; Saba Asif
Journal:  Cureus       Date:  2022-07-20

6.  Comparison of Intravenous Ketamine with Morphine in Pain Relief of Long Bones Fractures: a Double Blind Randomized Clinical Trial.

Authors:  Saeed Majidinejad; Mehrdad Esmailian; Mehrdad Emadi
Journal:  Emerg (Tehran)       Date:  2014

7.  The adverse effects of Ketamine on Procedural Sedation and Analgesia (PSA) in the Emergency Department.

Authors:  T S Dilip; Gina Maryann Chandy; Darpanarayan Hazra; Jagadesha Selvan; Priya Ganesan
Journal:  J Family Med Prim Care       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.